oxigeno medicinal liquido linde gas medicinal criogenico 99,5% v/v en recipientes criogenicos moviles
linde medica, s.l.u. - oxigeno - gas criogÉnico medicinal - 99,5 % v/v - oxigeno 99,5 % v/v - oxígeno
oxigeno medicinal liquido oxigen salud 99,5% v/v gas criogenico medicinal
oxigen salud s.a. - oxigeno - gas para inhalacion - 99,5 % v/v - oxigeno 99,5 % v/v - oxígeno
omeprazol tevagen 10 mg capsulas duras gastrorresistentes
teva pharma s.l.u. - omeprazol - excipientes: - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - omeprazol
omeprazol tecnigen 10 mg capsulas duras gastrorresistentes
tecnimede españa industria farmaceutica, s.a. - omeprazol - excipientes: - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - omeprazol
omeprazol ratio 10 mg capsulas duras gastrorresistentes
ratiopharm españa, s.a. - omeprazol - excipientes: - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - omeprazol
pantoprazol mundogen 20 mg comprimidos gastrorresistentes efg
laboratorios ranbaxy, s.l. - pantoprazol sodico sesquihidrato - excipientes: carbonato de sodio anhidro,manitol (e-421),manitol (e-421),carbonato de sodio anhidro,propilenglicol,laurilsulfato de sodio,propilenglicol - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - pantoprazol
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
noxafil 100 mg comprimidos gastrorresistentes
msd farmaceutica, c.a. - posaconazol - comprimidos gastrorresistentes - 100 mg
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
anagastra 20mg comprimidos gastrorresistentes
nycomed pharma sp.z.o.o. - pantoprazol sodico sesquihidrato - excipientes: carbonato sodico,manitol (e-421),propilenglicol,polisorbato 80,laurilsulfato de sodio - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - pantoprazol